Tely 22 of patients showed principal hypothyroidism. One particular hundred eighty-four sufferers (93 DTC
Tely 22 of patients showed main hypothyroidism. One hundred eighty-four patients (93 DTC and 91 MTC) have been administered in a phase II trial with motesanib (125 mg/ day orally)…